Speakers
Vishal Bali
Chief Executive Officer
Wockhardt Hospitals
Vishal Bali heads Wockhardt Hospitals, one of India’s largest healthcare providers with a national network of 15 superspeciality hospitals. He is responsible for driving corporate strategy, value growth and expansion of the chain across India and strengthening the international presence of the group hospitals. In his career spanning 18 years at the group, he has advanced through a series of leadership roles. Besides serving on the company’s board, he also serves on the advisory board of Harvard Medical International. He has recently been nominated as Indian Healthcare Leader of the year by Express Healthcare He received his BS and MBA from Bombay University.
Paul E. Berger, MD
Chief Executive Officer
NightHawk Radiology Holdings, Inc.
Paul Berger is a founding member and the CEO
of NightHawk Radiology Holdings.
He has published numerous scientific
articles and has given scores of presentations to both members of the
medical community and leaders in the healthcare management sector. He earned a Bachelor of Science degree from Tufts University and
a Medical Doctorate from the State University of New York-Downstate. He
received his radiology training at the University of Michigan and fellowship in pediatric neuroradiology at the Hospital for Sick
Children in Toronto. He is a member of the American College of Radiology.
David Boucher
President and Chief Operating Officer
Companion Global Healthcare, Inc., a wholly-owned
subsidiary of BlueCross BlueShield of South Carolina
David Boucher is responsible for Companion Global Healthcare, and leads in the US insurance movement to promote medical tourism. He has recently made deals with hospitals in Asia, Europe, and Latin America to make them part of Companion's
network. He previously was CEO of North and South Carolina facilities of Quorum Health Resources hospitals. He earned a BS in Community Health Administration at Slippery Rock State University (PA) and a Master of Public Health in Administration at the University of South Carolina. He has been quoted in more than 200 major business and consumer publications as well as NBC Nightly News.
David J. Brailer, MD, PhD
Chairman
Health Evolution Partners
Sarah Cairns-Smith
Partner and Managing Director
The Boston Consulting Group
Sarah Cairns-Smith received her PhD in Biochemistry from the Imperial Cancer Research Fund, London. She was a post-doctoral research scientist with a Muscular Dystrophy Association fellowship in the Center for Neurobiology at Columbia University. She then completed the MBA program at Columbia Business School (Distinction) and during this period she worked as an investment manager in venture capital with Schroder Ventures/Collinson Howe Lennox. Since joining The Boston Consulting Group (BCG) in 1996, she has worked primarily in drug R&D for biopharmaceutical companies and foundations. She has been based in the Boston and Paris offices. She is also a member of BCG’s global health leadership team.
David Cerino
General Manager
Consumer Health Solutions Group
Microsoft Corp.
David Cerino is responsible for the ongoing evolution of Microsoft HealthVault, a simple, security-enhanced platform that enables people to gather, manage and share their personal health information. Previoiusly, he served as chief marketing and product officer at Farelogix Inc., where he led development and execution of global marketing and product strategy for the company’s travel-industry technology. Before that, he was vice president and general manager at Orbitz LLC and led the corporate travel unit, Orbitz for Business. He holds an MBA from Florida Atlantic University, and a BS in mathematics and computer science from Wake Forest University in North Carolina.
George Church, PhD
Professor of Genetics and
Director, Lipper Center for Computational Genetics
Harvard Medical School
George Church has been an advisor to nearly two dozen companies, and is a co-founder of Knome, a personal genomics company. He completed his PhD at Harvard in Biochemistry and Molecular Biology with Walter Gilbert, developing the first direct genomic sequencing method in 1984. He co-initiated the Human Genome Project a few months later as a postdoctoral fellow at Biogen and UCSF. Innovations include molecular multiplexing and tags, homologous recombination methods, array DNA synthesizers and automated sequencing and software (used at Genome Therapeutics Corp. for the first commercial genome sequence — human pathogen, H. pylori, 1994). Current research focuses on the Personal Genome Project and synthetic biology.
Avery Comarow
Senior Writer
U.S. News & World Report
Avery Comarow has directed the “America's Best Hospitals” annual rankings since their debut in 1990 and last year oversaw the launch of the companion “America’s Best Children’s Hospitals” annual rankings. He has visited hospitals in India and Singapore for a cover story on medical travel. As a reporter, his special interests include medical quality and safety, epidemiology, and the flood of health information, not all of it credible, that threatens to drown patients in confusion. Science 80-86, Consumer Reports and Money magazine have been among his employers in 40 years of reporting and editing. He is on the board of advisors of the graduate science writing program at the University of California-Santa Cruz.
Robert A. DeNoble, MBA '72
President and Chief Executive Officer
The Marino Foundation for Integrative Medicine, Inc.
President, HBS Health Industry Alumni Association
Robert DeNoble has over 25 years of experience as a senior executive of healthcare organizations and as a consultant to health care providers and early stage biotech companies. In addition to his role as CEO of the Marino Foundation, he serves as a principal with RDA Healthcare Consulting, Inc., a company he co-founded to provide strategic, operational and financial management services to healthcare organizations. Prior to his current positions, he held senior positions with KPMG, LLP, Rhode Island Hospital, and McLean Hospital. He serves on the Board of the Austen Riggs Center, a national renowned psychiatric hospital located in western Massachusetts.
Deborah Dunsire, MD
President and Chief Executive Officer
Millennium Pharmaceuticals
Deborah Dunsire joined Millennium in 2005 with nearly 20 years of experience in commercial, operational, clinical and scientific aspects of a world-leading pharmaceutical business. Previously, she led the Novartis US Oncology business, managing 12 product launches and building the business from about $50 million to $2.1 billion in revenues over 10 years. She managed the merger of the Sandoz Pharmaceuticals and Ciba-Geigy oncology businesses. Earlier, as a clinical researcher, she was responsible for the implementation of global Phase II and Phase III studies across multiple therapeutic areas including immunology, endocrinology, neurology, dermatology, oncology and transplantation. She received her MD from the University of Witwatersand in Johannesburg, South Africa.
Beatrice Ellerin, MBA '95
Managing Director, Interbrand Wood
Founder, Past President, and Chairman
HBS Health Industry Alumni Association
Beatrice Ellerin, known as Bunny, is a Managing Director in the New York office of Interbrand Wood, the leading global brand consultancy focused exclusively on the healthcare industry. She leads the research division and is responsible for operational performance, business development, client management and staffing. She is also spearheading the firm’s efforts in the Health 2.0 space and recently launched the Pharma 2.0 Blog to track industry trends. Previously, she worked with a number of entrepreneurial, high growth healthcare companies including post-market surveillance company Clinsights, acquired by PPD, Inc. (NASDAQ: PPDI) in 2003, where she was Executive Vice President. She received a BA in Political Science from Columbia University. As Chairman, Founder and past President of HBS Health, she led the group's growth into a major HBS alumni association.
Jeffrey S. Flier, MD
Dean of the Faculty of Medicine
Harvard University
Jeffrey Flier, an endocrinologist and authority on the molecular causes of obesity and diabetes, was one of the first to demonstrate that diet-induced obesity in rodents is associated with increased leptin expression. His proposal that leptin serves as a switch from the fed to the starved state has fundamentally shaped the discourse of the field. A member of the HMS faculty since 1978, he was most recently chief academic officer of the Beth Israel Deaconess Medical Center (BIDMC), one of Harvard’s leading affiliated hospitals. He has authored over 200 scholarly papers and reviews. He holds a BS from the City College of New York and an MD from the Mount Sinai School of Medicine.
David Green, MBA ‘91
Co-Founder, President
Harvard Bioscience
Co-Chair, 9th Annual HBS Health Industry Alumni Conference
David Green is Co-Founder, President and a Director of Harvard Bioscience, named one of America’s Top 25 Fastest Growing Technology Companies in 2005 by Forbes Magazine. Harvard Bioscience’s products are used to advance life science research at virtually all pharmaceutical and biotechnology companies and research universities worldwide. Previously, he was a strategy consultant with Monitor Company, where his work advising the South African government received international media coverage. Before that, he was a brand manager at Lever Brothers (Unilever). He graduated with honors in physics from Oxford University, and received his Harvard MBA with distinction. He is a co-inventor on the patent Photoacoustic Spectroscopy Sample Array Vessel.
Kevin Green
Co-Founder & Managing Partner
TripleTree, LLC
Kevin Green leverages 30 years of broad industry experience and extensive transactional success as managing partner of a boutique investment bank. Previously, he held senior positions at private and public companies within the healthcare industry. He was CEO of Summit Medical, and as CEO of Integrated Medical Systems he grew the start-up to a high-growth business sold to Eli Lilly. He also served as an executive at Cycare, which grew into a NYSE company and was later sold to McKesson. He serves on a number of boards, is involved in various industry associations. He holds a BA and MBA from the University of San Diego.
Mireille Guiliano
Founder and former Chief Executive Officer
Clicquot, Inc.
Mireille Guiliano (Meer-ray Julie-ano) is the internationally best-selling author of French Women Don't Get Fat (2004), and its companion French Women for All Seasons (2006) as well as a long-time senior executive at the world’s largest luxury goods company, LVMH, where she brought trend-setting marketing innovation to Champagne Veuve Clicquot. She has written widely on food, wine, travel and lifestyle for a range of international publications. Her bestsellers—part memoir, part gastronomy and part practical philosophy guide—are stirring reminders of the importance of joie de vivre. She studied French and English literature at the Sorbonne and languages at the Institut Supérieur d'Interprétariat et de Traduction, and holds the French equivalent of a master's degree in English and German.
Richard G. Hamermesh, MBA '71, DBA '76
Professor of Management Practice
Harvard Business School
Richard Hamermesh teaches in the MBA Program and is the Faculty Chair of the HBS Healthcare Initiative. From 1987 to 2001, he was a co-founder and a Managing Partner of The Center for Executive Development, an executive education and development consulting firm. From 1976 to 1987, he was a member of the faculty of HBS. An investor and entrepreneur, he participated as a principal, director, and investor in the founding and early stages of over 20 organizations. He has served on the editorial board of the Harvard Business Review. He received his BA from the University of California, and his MBA and DBA from HBS.
Regina E. Herzlinger, DBA
Nancy R. McPherson Professor of Business Administration
Harvard Business School
Regina Herzlinger was the first woman to be tenured and chaired at HBS. She is widely recognized for her innovative research in health care, including her early predictions of the unraveling of managed care and the rise of consumer-driven health care and health care focused factories, two terms that she coined. Among her many bestselling books is her latest, Who Killed Health Care? (NY: McGraw-Hill, 2007). She has served on the Scientific Advisory Group to the U.S. Secretary of the Air Force and as a board member of many private and publicly-traded firms. She received her Bachelor’s Degree from MIT and her Doctorate from HBS.
James Allen Heywood
Co-founder and Chairman
PatientsLikeMe
Jamie Heywood co-founded PatientsLikeMe, a personalized research platform for patients, pharmaceutical and biotech companies as well as non-profits to better understand disease, improve care and accelerate the development of new treatments and biomarkers. He is the d’Arbeloff founding director of ALS Therapy Development Institute, the world’s first non-profit biotechnology company and served as its CEO from 1999 to 2007. An MIT engineer, he entered the field of translational research when his brother Stephen was diagnosed with ALS in 1998 at the age of 29. His work has been profiled in the New Yorker, 60 Minutes, Pulitzer Prize winner Jonathan Wiener’s book, His Brothers Keeper, and in the Sundance award winning documentary So Much So Fast.
Robert F. Higgins, MBA '70
Winner of Beatrice D. Ellerin Award for 2008
Senior Lecturer, Harvard Business School
General Partner and Founder, Highland Capital Partners
Bob Higgins co-created and teaches Entrepreneurship and Venture Capital in Health Care. He is a member of the Health Care Initiative, the Social Enterprise Initiative, and the Harvard Faculty Committee for the MD/MBA program. He founded Highland Capital Partners, a venture capital firm managing over $3.0 billion in assets from university endowments, pension funds, families, and corporations. He has been an investor in venture capital for over 25 years. Earlier, he was the Executive Director of the John A. Hartford Foundation in New York, a private foundation supporting medical research and health care management. From 1971 to 1973, he was the Assistant to the head of the International Division of the Treasury and as Assistant to the Secretary of Commerce. He is a graduate of Harvard College and HBS.
James Hummer, MBA ‘80
Founder and President, Luxemburg Capital
Founder, Former President & Chief Executive Officer
Whole Health Management
Co-Chair, 9th Annual HBS Health Industry Alumni Conference
Before heading his healthcare investment firm, Luxemburg Capital, Jim Hummer led Whole Health Management, an innovative provider of direct contract, on-site employee health services to leading self-insured companies, until it was merged into Walgreen Company earlier this year. Whole Health provided integrated health services including occupational, preventive, urgent and primary health care services. Clients include Sprint, Qualcomm, Florida Power & Light, Continental Airlines and Harrah’s Entertainment. Before that, he co-founded and was president of the Ivy Medical Group, an ambulatory health care company. Previously, he was Director of Planning and Human Resources at Martin Marietta Corporation’s Chemical Group. Earlier, he was with Deloitte, Haskins & Sells. He holds a BA in accounting from the University of Notre Dame and his MBA from Harvard.
Ori Karev
Chief Executive Officer
UnitedHealth International
Ori Karev is responsible for leading UnitedHealth International's growth and advancing its position as the leading global health and well-being company. Previously, he held global leadership positions with UnitedHealth Group, its parent, including CEO of Cross Border Solutions, which provides US benefits and care coordination to non-US payers. Before that, he was president and founder of a global health care M&A consulting firm, and president of MedSave USA. He holds a BA from Tel Aviv University, an MBA from the University of Hartford, and a JD from Cardozo School of Law. He is a member of the bar in New York and Connecticut.
Wolfgang Klietmann, MD, OPM 12
President and Medical Director, Mediconsulting, Inc.
Vice President, HBS Health
Co-Chair, HBS Health 9th Annual Health Industry Alumni Conference
Wolfgang Klietmann heads an international healthcare consulting company and is an appointed Lecturer in Pathology at Harvard Medical School. Previously on staff of the Department of Pathology at Massachusetts General Hospital, he also performed research as an Associate Scientist at the Wistar Institute of the University of Pennsylvania, headed a research group at the Max-Planck-Institute for Virus Research, and served on the medical faculty of the University of Tuebingen. He was Founder and Physician-in-Chief of a leading Institute of Laboratory Medicine in Germany. He received his medical education at the University of Freiburg (Germany), and at the Sorbonne and the University of Paris Medical School (France). He is a Fellow of the College of American Pathologists. He was recently elected Co-Chair of the Community Relations Committee and ex officio member of the Executive Committee for the 2007 BIO International Convention.
Michael Mahoney, MBA ‘98
President, Americas
International SOS
Michael Mahoney serves as President, Americas for International SOS, the world’s leading provider of medical assistance, international healthcare and security services. He leads all aspects of sales, marketing, client management and consulting services the United States, Canada, Mexico and South America. Prior to joining International SOS, he held a variety of sales, marketing, strategy and general management roles at AT&T, IBM, Amdahl Corporation and Mainspring Communications. Besides his MBA from HBS with High Distinction he holds degrees in Computer Science Engineering and Economics from the University of Pennsylvania.
The Honorable Benjamin E. Sasse, PhD
Assistant Secretary for Planning and Evaluation
US Department of Health and Human Services
Unanimously confirmed by the Senate in 2007, Ben Sasse oversees policy and legislative development, research, strategic planning, economic analysis, and policy coordination for the Department, with a special focus on the Centers for Medicare and Medicaid Services (CMS) and the FDA. He is on leave from a public policy professorship at the Lyndon B. Johnson School at The University of Texas. Previously, he was chief of staff to US Congressman Jeff Fortenberry (Nebraska) and US Assistant Attorney General Daniel Bryant. He began his career with the Boston Consulting Group. He was educated at Harvard, Oxford, and St. John's (Annapolis) before receiving his PhD from Yale.
Roy Schoenberg, MD, MPH
Chief Executive Officer, American Well Systems
Roy Schoenberg serves as American Well Systems' CEO and is the inventor of the American Well™ concept. Previously, he was the inventor and founder of CareKey Inc., a software vendor offering electronic health management systems. He continued to serve as Senior Vice President and Chief Internet Solutions Officer at Trizetto (NASDAQ:TZIX), following its acquisition of CareKey in 2005. He has written numerous books and publications on Medical Informatics, many published during his work at the Center for Clinical Computing at Harvard's Beth Israel Deaconess Hospital. He holds an MD from the Hebrew University Medical School and an MPH in Healthcare Management from Harvard University.
Phillip A. Sharp, PhD
Institute Professor
David H. Koch Institute for Integrative Cancer Research Massachusetts Institute of Technology
Phillip Sharp received the Nobel Prize in Physiology or Medicine in 1993 for his landmark work on the molecular biology of gene expression relevant to cancer and the mechanisms of RNA splicing. He is elected member of the National Academy of Sciences and recipient of the National Medal of Science. He earned a BA degree from Union College, KY, and a PhD in chemistry from the University of Illinois. He is a co-founder of Biogen (now Biogen Idec) and Alnylam and serves on the boards of both companies.
Susan E. Siegel
Partner
MDV—Mohr, Davidow Ventures
Susan (Sue) E. Siegel is a Partner at MDV, a top tier Silicon Valley venture firm where she leads investments in life sciences and healthcare, primarily focused on companies advancing personalized health and wellness. Previously, she was President & Director of Affymetrix, Inc. Sue serves on the board of directors of Navigenics, Pacific Biosciences, RainDance Technologies, and CellPoint Diagnostics. She is a board member at Silicon Valley’s Tech Museum, an advisor to the IOM, a Presidents’ Council member of the National Academies, an Advisory Council member at The Gladstone, and a Henry Crown Fellow at the Aspen Institute. She holds a BS, Biology from the University of Puerto Rico and received her MS in Biochemistry/Molecular Biology from Boston University Medical School.
Kelly Victory MS, MD, FACEP
President
Victory Health
Managing Partner, Health Services
Luxemburg Capital
Kelly Victory served as the Chief Medical Officer for Whole Health Management for over 5 years before leading a new Health & Wellness Division. She led the medical team of over 700 health professionals in the delivery of on-site health services. She developed innovative health risk and disease management programs that generated superior clinical outcomes for patients. She has over 15 years of clinical experience in trauma, emergency and ambulatory medicine. She is experienced in disaster preparedness, handling mass casualties and quality assurance programs. She holds a BS from Duke University, post graduate study at Oxford University, an MS in Clinical Psychology from University of Illinois and an MD from University of North Carolina.
Steven Wardell, MBA '00
Executive Director
ICS Development Corp.
Roundtable Chair, HBS Health 9th Annual Industry Conference
Steven Wardell is a health-industry corporate finance professional with
transactional and company-building experience in health services,
pharmaceuticals, biotechnology, and medical devices. Before joining IC
Sciences, he served as Vice President of Finance and Senior Director of
Business Development for Artisan Pharma, Inc., a Phase III, Boston-based
biotech start-up. Prior to Artisan Pharma, Inc., he was a Principal at
Apeiron Partners, a Boston-based health-industry investment bank and
venture capital fund. Mr. Wardell also has worked on Wall Street, where
he participated in over $20 billion worth of M&A and financing
transactions at Citigroup (Salomon Smith Barney) in the healthcare,
technology, and industrial sectors. He holds an MBA from Harvard
Business School, an MPhil in Economics from Cambridge University, and a
BA from Harvard College.
Tony L. White
Chairman and Chief Executive Officer
Applied Biosystems, Inc.
Tony L. White became Chairman of the Board, President and Chief Executive Officer of The Perkin-Elmer Corporation in 1995 and transformed that company, now Applied Biosystems Inc., into a global life sciences leader. He plans to retire upon the merger of Applied Biosystems with Invitrogen Corporation, which is expected to close during fall 2008. Prior to joining Perkin-Elmer, he was Executive Vice President and a member of the Office of the Chief Executive at Baxter International, Inc. Previously, he held a number of management positions both in U.S. and internationally during a 26-year career at Baxter. He serves on the Boards of Directors of C.R. Bard, Inc., Ingersoll-Rand Company Ltd., and SPRING Singapore. He graduated from Western Carolina University.
©2008 Harvard Business School Health Industry Alumni Association.
